Utilization of Hepatitis C Virus‐Infected Donor Hearts in Two Children and Two Young Adults: Initial Experience at a Pediatric Transplant Center
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14879 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Lauren E Kushner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA. Hauptthemen laut MEDLINE: Heart Transplantation, Antiviral Agents. Die Arbeit nennt 26 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Although adult transplant centers are successfully transplanting organs from hepatitis C virus (HCV)‐infected donors with detectable viral load by nucleic acid testing (NAT+) into HCV‐negative recipients, this practice has not yet been adopted widely by the pediatric heart transplant community.
Methods
We present a case series of four patients who received heart transplants from HCV NAT+ donors at a pediatric transplant center, including two pediatric patients < 18 years of age.
Results
All recipients tolerated a 12‐week course of glecaprevir/pibrentasvir and achieved a sustained virologic response with no HCV or liver complications with over 1 year of follow‐up (range 1.4–2.5 years). All four have had good post‐heart transplant outcomes with normal graft function and good functional status without rejection or cardiac allograft vasculopathy at time of last follow‐up.
Conclusions
This case series details the successful multidisciplinary implementation of a protocol to accept cardiac allografts from HCV NAT+ donors for transplantation into HCV negative recipients at our pediatric transplant center. With the limited donor pool in pediatrics and the morbidity associated with prolonged durations on the transplant waitlist, pediatric centers should consider utilizing organs from HCV NAT+ donors to broaden the donor pool. Future work should evaluate other organs beyond heart and optimal timing and duration of direct acting antiviral therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, California, USA.
- Department of Pharmacy, Lucile Packard Children's Hospital at Stanford, California, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Stanford University School of Medicine, California, USA.
- Division of Pediatric Cardiac Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, California, USA.
ORCID-Profile: Lauren E Kushner, Lauren Puckett, Joanne Lee, Hayley A Gans, Sruti Nadimpalli, Sharon Chen, Michael Ma, Sharon F Chen, Elizabeth L Profita
Zitieren
APA
Kushner, L. E., Puckett, L., Lee, J., Gans, H. A., Nadimpalli, S., Chen, S., Ma, M., Chen, S. F., & Profita, E. L. (2024). Utilization of Hepatitis C Virus‐Infected Donor Hearts in Two Children and Two Young Adults: Initial Experience at a Pediatric Transplant Center. Pediatric Transplantation. https://doi.org/10.1111/petr.14879
Vancouver
Kushner LE, Puckett L, Lee J, Gans HA, Nadimpalli S, Chen S, et al. Utilization of Hepatitis C Virus‐Infected Donor Hearts in Two Children and Two Young Adults: Initial Experience at a Pediatric Transplant Center. Pediatric Transplantation. 2024. doi:10.1111/petr.14879
BibTeX
@article{Kushner2024,
author = {Kushner, Lauren E and Puckett, Lauren and Lee, Joanne and Gans, Hayley A and Nadimpalli, Sruti and Chen, Sharon and Ma, Michael and Chen, Sharon F and Profita, Elizabeth L},
title = {Utilization of Hepatitis C Virus‐Infected Donor Hearts in Two Children and Two Young Adults: Initial Experience at a Pediatric Transplant Center},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14879}
}
EUVIMED